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Abstract: N-Heterocyclic carbene (NHC) metal complexes possess diverse biological 
activities but have yet to be extensively explored as potential chemotherapeutic agents.  
We have previously reported the synthesis of a new class of NHC metal complexes  
N-heterocyclic with acetate [IPr(BIAN)AuOAc] and chloride [IPr(BIAN)AuCl] ligands.  
In the experiments reported herein, the zebrafish embryos were exposed to serial dilutions 
of each of these complexes for 10–12 h. One hundred percent mortality was observed at 
concentrations ≥50 µM. At sub-lethal concentrations (10–30 µM), both compounds 
influenced zebrafish embryonic development. However, quite diverse categories of 
abnormalities were found in exposed embryos with each compound. Severe brain 
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deformation and notochord degeneration were evident in the case of [IPr(BIAN)AuOAc]. 
The zebrafish embryos treated with [IPr(BIAN)AuCl] exhibited stunted growth and 
consequently had smaller body sizes. A depletion of 30%–40% glutathione was detected  
in the treated embryos, which could account for one of the possible mechanism of 
neurotoxicity. The fact that these compounds are capable of both affecting the growth and 
also compromising antioxidant systems by elevating intracellular ROS production implies 
that they could play an important role as a new breed of therapeutic molecules. 
Keywords: BIAN; N-heterocyclic carbenes complexes; zebrafish; oxidative stress; 
neurotoxicity 
 
1. Introduction 
N-Heterocyclic carbene (NHC) metal complexes are easy to synthesize and functionalize since  
they form stronger bonds to metals and therefore form more stable metal complexes [1,2].  
The N-heterocyclic carbene (NHC) metal complexes also possess diverse biological activities and a few 
of them have been reported as potential chemotherapeutic agents [3–9]. The cationic Au(I) complexes 
of N-heterocyclic carbenes (NHCs) have been reported to have dual properties in a single molecule  
by targeting the mitochondria of cancer cells and selective inhibition of thioredoxin reductase [10–13]. 
The anti-mitochondrial properties of cationic, linear Au(I) N-heterocyclic carbene complexes have also  
been reported in a different study [14]. Even though the gold N-heterocyclic carbene complexes have been 
shown to have great commercial value for medical applications, there is often a lack of relevant safety 
and toxicology data. Most of the toxicological studies have been focused on in vitro models, which 
cannot represent the safety assessment in an entire organism. Toxicological studies in in vivo systems 
have greater significance over in vitro systems related to diversity in physiology and anatomy. 
Zebrafish represent an excellent in vivo model that is routinely used to test the in vivo toxicity of  
small compounds [15–17]. We have previously reported the synthesis of bis(imino)acenaphthene  
(BIAN)-supported N-heterocyclic carbene (BIAN N-NHC) complexes of gold N-heterocyclic and their 
antimicrobial and antifungal activities [18,19]. The objective of this study was to test the bioactivity and 
in vivo toxicity of these N-heterocyclic complexes in zebrafish embryos. 
2. Results 
2.1. BIAN N-Heterocyclic Carbene Gold Complexes Induce Lethality and Malformations in  
Zebrafish Embryos 
The structures of the newly synthesized BIAN N-heterocyclic carbene (NHC) complexes are  
given in Figure 1. The detailed synthesis procedure has been reported earlier as described in the  
experimental section. 
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Figure 1. Structures of the BIAN N-NHC gold complexes. 
Wild-type zebrafish embryos were exposed to gold acetate [IPr(BIAN)AuOAc] and gold chloride 
[IPr(BIAN)AuCl] complexes within the concentration range of 1–100 µM. Both compounds were safe 
in zebrafish embryos up to a concentration of 10 µM (Table 1) and no obvious abnormality was noticed 
in exposed embryos by either compound. A range of mortality (10%–60%) was observed when the 
embryos were exposed to concentrations between 30–50 µM. Concentrations higher than 50 µM were 
lethal and 100% mortality was observed with both compounds. Generally, the gold acetate complex 
[IPr(BIAN)AuOAc] turned out to be more toxic than the corresponding gold chloride [IPr(BIAN)AuCl] 
complex at the same molar concentration (Table 1). 
Table 1. Mortality of zebrafish embryos upon exposure to a range of concentrations of the 
BIAN-NHC gold carbene complexes. 
Concentration (µM) 
[IPr(BIAN)AuCl] [IPr(BIAN)AuOAc] 
Number of 
Embryos Used * 
% Mortality 
Number of 
Embryos Used * 
% Mortality 
Control (1% DMSO 
v/v treated embryos) 
54.00 ± 0.57 0.0 ± 0.00 50.00 ± 0.57 0.0 ± 0.00 
1 51.00 ± 0.59 0.0 ± 0.00 51.00 ± 0.57 0.0 ± 0.00 
10 50.00 ± 1.15 1.0 ± 1.00 50.00 ± 1.00 3.0 ± 0.5 
15 50.00 ± 1.15 3.0 ± 1.00 50.00 ± 1.52 5.0 ± 0.50 
30 51.00 ± 1.15 5.0 ± 0.57 51.00 ± 1.52 10.0 ± 1.14 
50 52.00 ± 1.15 25.0 ± 1.52 52.00 ± 1.15 60.0 ± 2.00 
100 50.00 ± 1.00 80.0 ± 0.57 50.00 ± 1.16 100 ± 0.00 
* Mean value from three independent experiments ± SD. 
2.2. The Gold Acetate Complex [IPr(BIAN)AuOAc] Induces Neurotoxicity by Hindering Brain 
Formation and Degeneration of the Notochord in Exposed Embryos 
Head hypoplasia (small head) was found to be the most prominent phenotype for zebrafish embryos 
that were exposed to [IPr(BIAN)AuOAc]. Normal brains with distinct morphological boundaries  
are clearly evident in the control embryos at 32 h post fertilization (hpf) (Figure 2A). The treated 
embryos, on the other hand, featured smaller heads with unclear boundaries between the brain 
subdivisions. These effects were particularly obvious in the mid–hindbrain region (Figure 2B,C). 
Moreover, the mid-hindbrain boundary, which was prominent in the case of the control embryos  
(Figure 2A), was not obvious in the treated embryos (Figure 2B,C). A dose dependent severity of  
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head hypoplasia was noticed in the exposed embryos. The incidence of head hypoplasia was 100%  
(n = 200 ± 28.86) at 30 µM concentration, while only 60% of the embryos (n = 210 ± 15.27) featured 
smaller heads after treatment with a 15 µM concentration of [IPr(BIAN)AuOAc] (Figure 2B,C). 
Furthermore, the otic vesicle (equivalent to the human ear) was significantly smaller in comparison with 
control at 15 µM exposure, while the otic vesicle was not evident in the case of the 30 µM treated 
embryos (white arrowhead in Figure 2A,B). 
 
Figure 2. BIAN NHC gold complexes affected the brain development in treated zebrafish 
embryos. Representative images of zebrafish embryos exposed to 50 µM of gold acetate, 
gold chloride and mock treated (1% DMSO v/v) embryos at 32 h post fertilization (hpf).  
The black arrows indicate the prominent mid–hindbrain boundaries between the posterior 
midbrain and the anterior hindbrain in the control embryos (A); the red arrow signifies the 
absence of clear mid-hindbrain boundaries between the posterior midbrain and the anterior 
hindbrain after exposure to the gold acetate compound (B) and the gold chloride compound 
(C). The otic vesicle (OV) was not developed in the gold acetate treated embryos. Abbreviations 
used: MHB = midbrain hindbrain boundary, HB = hindbrain, and OV = otic vesicle. 
The zebrafish embryos that had been exposed to 30 µM of [IPr(BIAN)AuOAc] exhibited 
degeneration of the notochord. It was noticed that the formation of the notochord was not interrupted in 
the [IPr(BIAN)AuOAc] exposed embryos. However, the notochord degenerated after it was formed. The 
deterioration of the notochord was more obvious at 72 hpf (Figure 3). The notochord cells lie completely 
within the sheath cells in the control embryos (Figures 3A; notochord represented by NC), whereas  
the notochord cells of the embryos that were treated with [IPr(BIAN)AuOAc] exhibited fragmented  
cells (Figure 3C,D, white arrows) throughout the notochord along with disorganized sheath cells  
(Figure 3C,D, black arrows). The severity of degeneration in the notochord was also dose dependent. At 
15µM concentration the degeneration occurred in a somewhat localized manner, mostly at the anterior 
trunk (Figure 3E,F, white arrows) and the sheath cells were also normal and straight (Figures 3E,F,  
black arrows). The degeneration of the notochord became severe in the 30 µM treated embryos and 
deteriorated notochord cells were prominent throughout the entire trunk along with disorganized sheath 
cells (Figure 3C,D, white arrows). 
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Figure 3. BIAN NHC Gold Complexes induced degeneration of the notochord in treated 
zebrafish embryos by inducing oxidative stress. Upper panel: Live photomicrographs of 
representative zebrafish embryos that had been treated with mock (1% DMSO v/v) (A,B); 
30 µM of [IPr(BIAN)AuOAc] (C,D) and IPr(BIAN)AuCl 50 µM (D,F) at three dpf.  
The notochord (represented as NC in the images) in the mock treated embryos lies flat and 
is located between the organized layers of the sheath cells (indicated by black arrows).  
In contrast, the embryos that were treated with [IPr(BIAN)AuOAc] exhibited complete 
degeneration of the entire notochord (see black arrows in D); It is also noteworthy that the 
distinct boundaries between the sheath layers are absent in the case of the treated embryos 
(Compare black arrows in B,D); The [IPr(BIAN)AuCl] treated embryos also exhibited 
degeneration of the notochord, but in a somewhat localized manner, mostly at the  
anterior trunk (white arrows in F); The sheath cells were also normal in the case of the 
[IPr(BIAN)AuCl] treated embryos (black arrows F); Lower panel: glutathione (GSH) levels 
in zebrafish embryos exposed for 24 h. Each histogram represents the mean ± SD of three 
independent experiments. * p < 0.05 vs. control. 
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The presence of oxidative stress could lead to neurodegeneration. In order to check whether these 
compounds induced any oxidative stress in exposed zebrafish embryos, the level of total glutathione 
(GSSG + GSH) in the treated embryos was measured. A 40% reduction in the total glutathione was 
detected in the zebrafish embryos that had been treated with 30 µM of the gold acetate complex 
[IPr(BIAN)AuOAc] while the gold chloride complex [IPr(BIAN)AuCl] reduced the glutathione by  
25% at 30 µM (Figure 3) lower panel. 
2.3. The BIAN NHC Gold Chloride Complex [IPr(BIAN)AuCl] Exposure Induced Delay in 
Development, Stunted Growth and Organ Malformation in Zebrafish Embryos 
The zebrafish embryos exposed to 30 µM concentrations of [IPr(BIAN)AuCl] failed to grow  
and remained smaller as compared with the untreated control embryos (Figure 4A). Careful body 
measurements revealed that the mean body lengths from the head to the tip of tail of the untreated 
embryos (mean number of embryos 30 ± 1.6) were 0.3939 ± 0.002 cm, while the mean body lengths of 
the treated embryos (mean number of embryos 30 ± 1.7) were 0.2168 ± 0.0049 (p values 2.72625 × 10‒53) 
which is almost 62% smaller than that of the untreated or mock (1% DMSO v/v) treated embryos. In 
order to check, whether these short bodied embryos could regain the normal size if they were raised 
without compound after a short exposure. The embryos were exposed to [IPr(BIAN)AuCl] for 12 h and 
subsequently raised in a compound free medium for another 96 h. Interestingly, these short bodied 
embryos failed to reach to normal size (Figure 4B). The exposed embryos also had malformed organs. 
For example the control embryos had normal swim bladders (shown by red arrows in Figure 4B), 
whereas the exposed embryos did not develop swim bladder. The exposed embryos also had malformed 
snouts (blue arrow head in Figure 4B). 
 
Figure 4. The [IPr(BIAN)AuCl] exposure induced delay in development decrease growth 
and organ malformation in zebrafish embryos. Representative live images of the control and 
treated zebrafish embryos at three dpf (A); and five dpf (B). The body size comparison of the 
mock treated embryos (1% DMSO v/v) and the 30 µM [IPr(BIAN)AuCl] treated embryos at 
three dpf revealed that the latter treated embryos were significantly smaller in size. The swim 
bladder (red arrow B) is evident in the control embryo but fails to form in the case of the 
treated embryos (red arrow). The mouth structure snout (blue arrow head) also did not form 
in treated embryos. The treated embryos failed to grow to normal size and remained small 
when observed at five dpf. In order to avoid bias, the images were captured by placing treated 
and untreated embryos side by side at the same magnification). 
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The mechanism by which the [IPr(BIAN)AuCl] affected the growth of zebrafish embryos is 
unknown. A smaller yolk and leakage of yolk contents was observed in the case of the exposed embryos 
(Figure 5B). It was suspected that un-availability of nutrients due to the leakage of yolk might be the 
reason for the stunted growth. The yolk is rich in nutrients and considered to be the primary source of 
nutrition for zebrafish embryos for four to five days. In order to test this hypothesis, the untreated 
zebrafish embryos were raised up to 24 hpf, following which the yolk was punctured using sterile 1cc 
syringe needles (Figure 5C) and allowed to grow up to 72 hpf. Most (12/15) of the embryos died when 
the yolk was punctured. However, the embryos that survived had no significant difference in body 
lengths as compared with that of the control (Figure 5D). This implies that malnutrition was not the 
exclusive reason for the stunted embryonic growth and that [IPr(BIAN)AuCl] could have influenced the 
embryonic growth by interfering with the overall cell proliferation and growth. 
 
Figure 5. The shortened bodies that were observed by treatment with the BIAN NHC gold 
chloride complex [IPr(BIAN)AuCl] were not due to the leakage of yolk contents. The control 
embryos at 32 hpf had intact yolks and there was no leakage of the yolk content (A);  
However, leaky yolk was evident in the zebrafish embryos that had been treated with the 
BIAN NHC gold chloride complex [IPr(BIAN)AuCl] 30 µM (black arrow head in B) and 
this could be the reason for the shortened bodies; In order to validate this hypothesis, the 
yolks of the untreated embryos were punctured at 24 hpf (C, black arrows); and these 
embryos were allowed to grow until three dpf. Even though there was some developmental 
delay for the embryos that had been punctured, they grew to the same size as the control 
(compare the top embryos to D). The images shown in (D) were taken using the same 
magnification by placing the embryos side by side. 
3. Discussion 
Anticancer drugs that are widely used have significant side effects such as neurotoxicity, 
nephrotoxicity, and the development of resistance in some cancer cells [20]. In order to overcome these 
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limitations, a variety of different metal-containing complexes are currently being studied as potential 
anticancer agents [21]. Among such compounds, the metal N-heterocyclic carbene (NHC) complexes 
are highly stable and easy derivatization makes them suitable candidates for drug development [22,23]. 
Of the various metal NHC complexes that have been prepared thus far, the silver and gold NHC 
complexes show considerable promise as anti-microbial and anticancer agents [24]. At the present time, 
the biomedical applications of gold N-heterocyclic carbene are in their infancy, and the available 
literature is limited to only a few reports [25–29]. There is very little data on the effects of the gold  
N-heterocyclic carbene complexes (and other metallic heterocyclic carbene complexes) on zebrafish 
embryonic development, with only two studies having addressed the mortality of zebrafish embryos  
with respect to ruthenium based N-heterocyclic carbene complexes. The results of these studies are  
also contradictory: in one study the ruthenium-N-heterocyclic carbene complexes were reported to be 
harmless to zebrafish embryos under all tested conditions, [28] while, in the other, greater than 50% 
mortality was reported following exposure of the embryos to ruthenium(II) N-heterocyclic carbene 
complexes for 48 h [29]. This striking disparity suggests that the lethality or toxicity of a tested complex 
depends primarily on the nature of the transition metal that is incorporated in the N-heterocyclic carbene 
complex. For example, in the studies described above, the ruthenium(II) benzimidazolylidene carbene 
complexes were found to be more toxic than the benzimidazolylidene carbene free ruthenium complexes. 
Bearing this, and the above discussion in mind, the bioactivity of the BIAN N-heterocyclic gold carbene 
complexes in zebrafish embryos could be due to structural modification. In particular, the addition of  
an “acetate” group could have contributed to the overall toxic character. In fact, the presence of  
various combinations of acetate groups have been shown to induce mortality in exposed zebrafish  
embryos [30,31]. The high mortality in response to the gold acetate complex [IPr(BIAN)AuOAc] that 
was encountered in the present study is clearly in accord with results reported for other studies [30]. 
Moreover, ruthenium and gold N-heterocyclic carbene complexes have been reported to be toxic to other 
animal models as well [26,27]. 
In the present study the gold acetate complex [IPr(BIAN)AuOAc] targeted the neurogenesis in 
zebrafish embryos either by impeding brain formation or causing the degeneration of notochord.  
The precise mechanisms by which this compound impaired the neurogenesis in zebrafish embryos are 
not known. However, one candidate mechanism is oxidative stress, since this is usually regarded as the 
major contributor to neurodegeneration and CNS injury [32–35]. Oxidative stress can also induce 
neuronal cell death and is considered a common pathway in various forms of neuronal cell death in 
neurological diseases [36,37]. 
In an oxidative stress state the intracellular glutathione decreases with an elevated level of  
oxygen-derived free radicals [38–40]. Glutathione is a critical component of antioxidant defense and  
has been linked directly to oxidative stress. Glutathione plays an important role in protecting neurons 
against oxidative damage and metabolic insults by detoxifying 4-hydroxynonenal (HNE) [41].  
A depletion of glutathione caused nerve cell death in immature cortical neurons and a neuronal cell  
line [42]. The neurotoxicity and notochord neurodegeneration was noticed in zebrafish embryos that had 
been exposed to [IPr(BIAN)AuOAc], and consequently 40% reduction in the total glutathione level was 
found in treated embryos. This reduction of glutathione might have elevated the oxidative stress in the 
exposed embryos. Hence the oxidative stress could be one of the mechanisms for possible neurotoxicity 
associated with [IPr(BIAN)AuOAc] in zebrafish embryos. The generation of ROS in cultured tumour 
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cells by two species of gold(I) NHC complexes has been reported [43,44], but there is no report so far, 
about the status of oxidative stress in live animals by exposure to any of the gold NHC complexes. 
The literature about the growth inhibition and reduced body size that has been observed in zebrafish 
embryos exposed to [IPr(BIAN)AuCl] is very limited. Only one report described a somewhat similar 
phenotype. Titanium dioxide nanoparticles (TiO2NPs) produced similar kind of stunted growth,  
delayed metamorphosis, malformations, organ pathology, and DNA damage in exposed zebrafish larvae.  
The induction of reactive oxygen species (ROS) was believed to be the mechanism that caused toxicities 
in zebrafish embryos by titanium dioxide nanoparticles (TiO2NPs) [45]. The [IPr(BIAN)AuCl] exposure 
also induced a 30% reduction in the total glutathione level which in turn could have compromised the 
oxidative status in exposed zebrafish embryos. In agreement with the above mentioned study, the oxidative 
stress could possibly be one of the mechanisms for growth inhibition in [IPr(BIAN)AuCl] embryos. 
The development of organs shares many similarities with cancer development in terms of biological 
behaviour and molecular basis [46,47]. This means that if a certain type of molecule(s) interrupt  
the formation of an organ during embryonic development by suppressing the expression of crucial 
transcription factors which are needed for cell proliferation, it is quite likely that the same set of 
compounds would target those transcription factors in pathological states as well. Moreover, very 
recently, conserved gene expression was identified by comparing oncogenesis in the human cerebellar 
tumour, MB, and the developing wild-type mouse cerebellum during postnatal days 1–60 [48]. In our 
experiment, the BIAN N-heterocyclic gold carbene complexes specifically interrupted brain formation 
so it is very important to find out the molecular target(s) affected after the exposure of these compounds 
in zebrafish embryos in order to predict the therapeutic application of these molecules in respect to 
human brain tumours. Our unpublished results with cancer cells [49] have revealed that both of these 
compounds have shown cytotoxicity towards two types of human cancer cells line namely liver 
carcinoma (HepG2) and breast carcinoma (MCF7). Both compounds affected the viability of cancer 
cells with IC50 values less than micro molar range. However, these compounds did not induce any kind 
of abnormalities in zebrafish embryos up to a 10 µM range. This means that at low concentrations  
(1–10 µM) they might be cytotoxic to cancer cells but safe to be used in animals (at least in the case  
of zebrafish embryos) which in turn suggests the potential use of these compounds as promising 
therapeutics drugs. 
4. Experimental Section 
4.1. Biological Screening 
4.1.1. Animals 
Wild type (AB/Tubingen tab-14) zebrafish were obtained from the Zebrafish International Resource 
Center (ZIRC University of Oregon, Eugene, OR, USA). Wild type zebrafish were kept under the 
standard laboratory conditions of 28 °C on a 14 h light/10 h dark photoperiod in fish water, consisting 
of reverse osmosis water supplemented with a commercially available salt (0.6% Instant Ocean salt).  
All the embryos used in these experiments were less than 120 h post fertilization and hence do not need 
the approval of Animal Care and Use Committee as stated by Strahle [49]. However, all the experiments 
were carried out in accordance with the International Animal Use Guidelines. 
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4.1.2. Embryo Treatment 
Embryos were obtained by natural pairwise mating and were raised up to the shield stage (6 h post 
fertilization). The gold complexes were re-suspended in cell culture grade dimethyl sulfoxide (DMSO) 
(D8418 Sigma LLC. St. Louis, MO, USA) at a stock concentration of 10 mM. The synchronized staged 
embryos (n = 30–35) with chorion were exposed to serial dilutions of the gold complexes in the 
embryonic media (5.0 mM NaCl, 0.17 mM KCl, 0.33 mM CaCl2, 0.33 mM MgSO4). The mock controls 
were 1% DMSO (v/v) treated embryos. The embryos remained exposed for the indicated times of 
treatment in an air incubator at 28 °C. This treatment was repeated at least three times using different 
batches of embryos each time. The cumulative mortalities and morphological defects were assessed at 
24, 48, 72, 96 and 144 h post fertilization. The types of malformations that were considered were 
pericardial oedema (PE), yolk sac oedema (YE), yolk sac malformation (YM), bent spine (BS), brain 
deformation (BrD), notochord deformation (NC), tail malformation (TM), stunted or delayed growth 
(SG) and shortened body axes (SB). 
4.1.3. Microscopy and Photography 
All images were recorded using a Nikon Eclipse E600 Binocular Microscope equipped with a Nikon 
Digital Camera (Nikon Corporation; Konan, Minato-ku, Tokyo, 108-6290 Japan), model DXM1200F. 
4.1.4. Measurement of Glutathione (GSH) Level in Zebrafish Embryos 
The changes in the GSH levels in the exposed embryos were determined using a commercially 
available kit (Glutathione Assay Kit, Catalogue Number CS0260; Sigma- Aldrich 3050 Spruce Street, 
St Louis, MO, USA). In order to check the total glutathione level in the zebrafish, the embryos were 
exposed to the gold carbene NHC complexes for 12 h. Following exposure, embryos (both treated and 
control) were rinsed three times in PBS. The embryos were then homogenized in a cold assay buffer 
(100 mM potassium phosphate buffer, pH 7.0, with 1 mM EDTA). The resulting homogenate was 
centrifuged at 10,000 rpm for 15 min at 4 °C, and the supernatant was collected and deproteinated by 
treatment with 5% 5-sulphosalicylic acid. The total glutathione level was then measured by reading the 
samples in a plate reader. The amount of glutathione in mock treated embryos was normalized as 100%. 
The level of glutathione in exposed embryos was calculated as follow: 
Total glutathione level = (Mean absorbance in exposed embryos)/(Mean absorbance in control 
embryos) × 100. 
4.2. Chemistry 
Syntheses of BIAN NHC Gold Complexes 
The BIAN NHC gold complexes [IPr(BIAN)AuCl] and [IPr(BIAN)AuOAc] were synthesized as 
reported previously [50]. 
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4.3. Statistical Analysis 
The data in Table 1 is expressed as mean ± S.D., using the values obtained from three independent 
experiments. Statistical analysis was performed by one-way analysis of variance (ANOVA) using Origin 
v6.1052 (Origin Lab Corporation, Northampton, MA, USA). Unless stated otherwise, the chosen level 
of statistical significance was p < 0.05. 
5. Conclusions 
We have previously reported the antimicrobial and antifungal properties of N-heterocyclic carbene 
complexes [18,19]. This study has shown the bioactivity and in vivo cytotoxicity of these compounds in 
an entire organism i.e., zebrafish embryos. All together the antimicrobial, antifungal, anticancer 
(unpublished data) [48]  and elevation of oxidative stress in zebrafish embryos as well as in cancer cells 
implies that these compounds have the potential to be developed as new class of therapeutics. 
Acknowledgments 
The authors extend their sincere appreciation to the Deanship of Scientific Research at King Saud 
University for funding this research group No. RGP-284 and Robert A. Welch Foundation (Grant F-0003). 
Author Contributions 
Muhammad Farooq designed the study conducted the experiments in zebrafish embryos, performed 
statistical analysis of the data, made the tables and figures, and wrote the manuscript. Nael Abu Taha 
measured the glutathione level and interpreted the data. Rachel R. Butorac, Daniel Anthony Evans and 
Ahmed A. Elzatahry synthesised the compounds, and edited the manuscript. Elsayed Ahmed Elsayed, 
Mohammad A. M. Wadaan, Salem S. Al-Deyab and Alan H. Cowley conceived of the study, participated 
in its design and drafted the manuscript. All of the authors read and approved the final manuscript. 
Conflicts of Interest 
The authors declare no conflict of interest. 
References 
1. Herrmann, W.A.; Köcher, C. N-Heterocyclic carbenes. Angew. Chem. Int. Ed. Engl. 1997, 36, 
2162–2187. 
2. McGuinness, D.S.; Cavell, K.J.; Skelton, B.W.; White, A.H. Zerovalent palladium and nickel 
complexes of heterocyclic carbenes:  Oxidative addition of organic halides, carbon-carbon coupling 
processes, and the heck reaction. Organometallics 1999, 18, 1596–1605. 
3. Hopkinson, M.N.; Richter, C.; Schedler, M.; Glorius, F. An overview of N-heterocyclic carbenes. 
Nature 2014, 510, 485–496. 
4. Aher, S.B.; Muskawar, P.N.; Thenmozhi, K.; Bhagat, P.R. Recent developments of metal  
N-heterocyclic carbenes as anticancer agents. Eur. J. Med. Chem. 2014, 81, 408–419. 
Int. J. Mol. Sci. 2015, 16 24729 
 
 
5. Hu, C.; Li, X.; Wang, W.; Zhang, R.; Deng, L. Metal-N-heterocyclic carbene complexes as  
anti-tumor agents. Curr. Med. Chem. 2014, 21, 1220–1230. 
6. Liu, W.K.; Gust, R. Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs. 
Chem. Soc. Rev. 2013, 42, 755–773. 
7. Gautier, A.; Cisnetti, F. Advances in metal-carbene complexes as potent anti-cancer agents. 
Metallomics 2012, 4, 23–32. 
8. Hindi, K.M.; Panzner, M.J.; Tessier, C.A.; Cannon, C.L.; Youngs, W.J. The medicinal applications 
of imidazolium carbene-metal complexes. Chem. Rev. 2009, 109, 3859–3884. 
9. Teyssot, M.L.; Jarrousse, A.S.; Manin, M.; Chevry, A.; Roche, S.; Norre, F.; Beaudoin, C.; Morel, L.; 
Boyer, D.; Mahiou, R.; et al. Metal-NHC complexes: A survey of anti-cancer properties. Dalton Trans. 
2009, 6894–6902. 
10. Raubenheimer, H.G.; Cronje, S. Carbene complexes of gold: Preparation, medical application and 
bonding. Chem. Soc. Rev. 2008, 37, 1998–2011. 
11. Rubbiani, R.; Can, S.; Kitanovic, I.; Alborzinia, H.; Stefanopoulou, M.; Kokoschka, M.; 
Mönchgesang, S.; Sheldrick, W.S.; Wölfl, S.; Ott, I. Comparative in vitro evaluation of  
N-heterocyclic carbene gold(I) complexes of the benzimidazolylidene type. J. Med. Chem. 2011, 
54, 8646–8657. 
12. Meyer, A.; Oehninger, L.; Geldmacher, Y.; Alborzinia, H.; Wolfl, S.; Sheldrick, W.S.; Ott, I. 
Gold(I) N-heterocyclic carbene complexes with naphthalimide ligands as combined thioredoxin 
reductase inhibitors and DNA intercalators. Chem. Med. Chem. 2014, 9, 1794–1800. 
13. Baker, M.V.; Barnard, P.J.; Berners-Price, S.J.; Brayshaw, S.K.; Hickey, J.L.; Skelton, B.W.; 
White, A.H. Cationic, linear Au(I) N-heterocyclic carbene complexes: Synthesis, structure and  
anti-mitochondrial activity. Dalton Trans. 2006, 3708–3715. 
14. Hill, A.J.; Teraoka, H.; Heideman, W.; Peterson, R.E. Zebrafish as a model vertebrate for 
investigating chemical toxicity. Toxicol. Sci. 2005, 86, 6–19. 
15. Parng, C.; Seng, W.L.; Semino, C.; McGrath, P. Zebrafish: A preclinical model for drug screening. 
Assay Drug Dev. Technol. 2002, 1, 41–48. 
16. Peterson, R.T.; Link, B.A.; Dowling, J.E.; Schreiber, S.L. Small molecule developmental screens reveal 
the logic and timing of vertebrate development. Proc. Natl. Acad. Sci. USA 2000, 97, 12965–12969. 
17. Elzatahry, A.A.; Al-Enizi, A.M.; Elsayed, E.A.; Butorac, R.R.; Al-Deyab, S.S.; Wadaan, M.A.; 
Cowley, A.H. Nanofiber composites containing N-heterocyclic carbene complexes with antimicrobial 
activity. Int. J. Nanomed. 2012, 7, 2829–2832. 
18. Butorac, R.R.; Al-Deyab, S.S.; Cowley, A.H. Antimicrobial properties of some 
bis(imino)acenaphthene (BIAN)-supported N-heterocyclic carbene complexes of silver and gold. 
Molecules 2011, 16, 2285–2292. 
19. Berners-Price, S.J. Activating platinum anticancer complexes with visible light. Angew. Chem. Int. 
Ed. Engl. 2011, 50, 804–805. 
20. Nardon, C.; Boscutti, G.; Fregona, D. Beyond platinums: Gold complexes as anticancer agents. 
Anticancer Res. 2014, 34, 487–492. 
21. Melaiye, A.; Simons, R.S.; Milsted, A.; Pingitore, F.; Wesdemiotis, C.; Tessier, C.A.; Youngs, W.J. 
Formation of water-soluble pincer silver(I)-carbene complexes: A novel antimicrobial agent.  
J. Med. Chem. 2004, 47, 973–977. 
Int. J. Mol. Sci. 2015, 16 24730 
 
 
22. Hickey, J.L.; Ruhayel, R.A.; Barnard, P.J.; Baker, M.V.; Berners-Price, S.J.; Filipovska, A. 
Mitochondria-targeted chemotherapeutics: The rational design of gold(I) N-heterocyclic carbene 
complexes that are selectively toxic to cancer cells and target protein selenols in preference to thiols. 
J. Am. Chem. Soc. 2008, 130, 12570–12571. 
23. Ozdemir, I.; Temelli, N.; Gunal, S.; Demir, S. Gold(I) complexes of N-heterocyclic carbene ligands 
containing benzimidazole: Synthesis and antimicrobial activity. Molecules 2010, 15, 2203–2210. 
24. Muenzner, J.K.; Biersack, B.; Kalie, H.; Andronache, I.C.; Kaps, L.; Schuppan, D.; Sasse, F.; 
Schobert, R. Gold(I) biscarbene complexes derived from vascular-disrupting combretastatin A-4 
address different targets and show antimetastatic potential. Chem. Med. Chem. 2014, 9, 1195–1204. 
25. Ciftci, O.; Beytur, A.; Vardi, N.; Ozdemir, I. Evaluation of reproductive toxicity in male rats treated 
with novel synthesized ruthenium(II) and gold(I)-NHC complexes. Drug Dev. Ind. Pharm. 2012, 
38, 40–46. 
26. Ciftci, O.; Ozdemir, I.; Cakir, O.; Demir, S. The determination of oxidative damage in heart tissue 
of rats caused by ruthenium(II) and gold(I) N-heterocyclic carbene complexes. Toxicol. Ind. Health 
2011, 27, 735–741. 
27. Alfaro, J.M.; Prades, A.; del Carmen Ramos, M.; Peris, E.; Ripoll-Gomez, J.; Poyatos, M.;  
Burgos, J.S. Biomedical properties of a series of ruthenium-N-heterocyclic carbene complexes 
based on oxidant activity in vitro and assessment in vivo of biosafety in zebrafish embryos. 
Zebrafish 2010, 7, 13–21. 
28. Oehninger, L.; Stefanopoulou, M.; Alborzinia, H.; Schur, J.; Ludewig, S.; Namikawa, K.;  
Munoz-Castro, A.; Koster, R.W.; Baumann, K.; Wolfl, S.; et al. Evaluation of arene ruthenium(II) 
N-heterocyclic carbene complexes as organometallics interacting with thiol and selenol containing 
biomolecules. Dalton Trans. 2013, 42, 1657–1666. 
29. Chen, J.; Chen, Y.; Liu, W.; Bai, C.; Liu, X.; Liu, K.; Li, R.; Zhu, J.H.; Huang, C. Developmental 
lead acetate exposure induces embryonic toxicity and memory deficit in adult zebrafish. 
Neurotoxicol. Teratol. 2012, 34, 581–586. 
30. Strmac, M.; Braunbeck, T. Effects of triphenyltin acetate on survival, hatching success, and liver 
ultrastructure of early life stages of zebrafish (Danio rerio). Ecotoxicol. Environ. Saf. 1999, 44, 25–39. 
31. Behl, C.; Skutella, T.; Lezoualch, F.; Post, A.; Widmann, M.; Newton, C.J.; Holsboer, F. 
Neuroprotection against oxidative stress by estrogens: Structure-activity relationship. Mol. Pharmacol. 
1997, 51, 535–541. 
32. Halliwell, B. Oxidative stress and neurodegeneration: Where are we now? J. Neurochem. 2006, 97, 
1634–1658. 
33. Gandhi, S.; Abramov, A.Y. Mechanism of oxidative stress in neurodegeneration. Oxid. Med.  
Cell. Longev. 2012, doi:10.1155/2012/428010. 
34. Barber, S.C.; Mead, R.J.; Shaw, P.J. Oxidative stress in ALS: A mechanism of neurodegeneration 
and a therapeutic target. BBA Mol. Basis Dis. 2006, 1762, 1051–1067. 
35. Evans, P.H. Free radicals in brain metabolism and pathology. Br. Med. Bull. 1993, 49, 577–587. 
36. Gutowicz, M. The influence of reactive oxygen species on the central nervous system.  
Postepy Hig. Med. Dosw. 2011, 65, 104–113. 
37. Halliwell, B. Reactive oxygen species and the central nervous system. J. Neurochem. 1992, 59, 
1609–1623. 
Int. J. Mol. Sci. 2015, 16 24731 
 
 
38. Bironaite, D.; Ollinger, K. The hepatotoxicity of rhein involves impairment of mitochondrial 
functions. Chem. Biol. Interact. 1997, 103, 35–50. 
39. Aoyama, K.; Nakaki, T. Glutathione in cellular redox homeostasis: Association with the excitatory 
amino acid carrier 1 (EAAC1). Molecules 2015, 20, 8742–8758. 
40. Bains, J.S.; Shaw, C.A. Neurodegenerative disorders in humans: The role of glutathione in oxidative 
stress-mediated neuronal death. Brain Res. Rev. 1997, 25, 335–358. 
41. Li, Y.; Maher, P.; Schubert, D. A role for 12-lipoxygenase in nerve cell death caused by glutathione 
depletion. Neuron 1997, 19, 453–463. 
42. Nandy, A.; Dey, S.K.; Das, S.; Munda, R.N.; Dinda, J.; Das Saha, K. Gold(I) N-heterocyclic  
carbene complex inhibits mouse melanoma growth by p53 upregulation. Mol. Cancer 2014, 13, 
doi:10.1186/1476-4598-13-57. 
43. Rubbiani, R.; Kitanovic, I.; Alborzinia, H.; Can, S.; Kitanovic, A.; Onambele, L.A.; Stefanopoulou, M.; 
Geldmacher, Y.; Sheldrick, W.S.; Wolber, G.; et al. Benzimidazol-2-ylidene gold(I) complexes  
are thioredoxin reductase inhibitors with multiple antitumor properties. J. Med. Chem. 2010, 53, 
8608–8618. 
44. Bar-Ilan, O.; Chuang, C.C.; Schwahn, D.J.; Yang, S.; Joshi, S.; Pedersen, J.A.; Hamers, R.J.; 
Peterson, R.E.; Heideman, W. TiO2 nanoparticle exposure and illumination during zebrafish 
development: Mortality at parts per billion concentrations. Environ. Sci. Technol. 2013, 47,  
4726–4733. 
45. Ma, Y.; Zhang, P.; Wang, F.; Yang, J.; Yang, Z.; Qin, H. The relationship between early embryo 
development and tumourigenesis. J. Cell. Mol. Med. 2010, 14, 2697–2701. 
46. Monk, M.; Holding, C. Human embryonic genes re-expressed in cancer cells. Oncogene 2001, 20, 
8085–8091. 
47. Kho, A.T.; Zhao, Q.; Cai, Z.; Butte, A.J.; Kim, J.Y.; Pomeroy, S.L.; Rowitch, D.H.; Kohane, I.S. 
Conserved mechanisms across development and tumorigenesis revealed by a mouse development 
perspective of human cancers. Genes Dev. 2004, 18, 629–640. 
48. Farooq, M.K.; Nael, A.T.; Butorac, R.; Evans, D.A.; Elzatahry, A.A.; Wadaan, M.A.M.; Cowley, A.H. 
BIAN N-heterocyclic gold carbene complexes induced cytotoxicity in human cancer cells via 
upregulating oxidative stres. Asian Pac. J. Cancer Prev. 2015, in press. 
49. Strahle, U.; Scholz, S.; Geisler, R.; Greiner, P.; Hollert, H.; Rastegar, S.; Schumacher, A.; 
Selderslaghs, I.; Weiss, C.; Witters, H.; et al. Zebrafish embryos as an alternative to animal 
experiments—A commentary on the definition of the onset of protected life stages in animal welfare 
regulations. Reprod. Toxicol. 2012, 33, 128–132. 
50. Vasudevan, K.V.; Butorac, R.R.; Abernethy, C.D.; Cowley, A.H. Synthesis and coordination 
compounds of a bis(imino)acenaphthene (BIAN)-supported N-heterocyclic carbene. Dalton Trans. 
2010, 39, 7401–7408. 
© 2015 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article 
distributed under the terms and conditions of the Creative Commons Attribution license 
(http://creativecommons.org/licenses/by/4.0/). 
